Please ensure Javascript is enabled for purposes of website accessibility

Community Minds

Spravato Esketamine Therapy: A New Path for Treatment-Resistant Depression

Published Last updated

Spravato Esketamine Therapy

Spravato esketamine therapy, an FDA‑approved nasal spray given in clinics, can quickly lift treatment‑resistant depression when standard antidepressants fail.

For individuals living with severe depression that hasn’t improved through conventional methods, the journey toward healing can feel long and frustrating. But new therapies are opening the door to relief, especially for those who haven’t responded to traditional antidepressants. One of the most promising options is Spravato esketamine therapy, an FDA-approved treatment designed for people with treatment-resistant depression or suicidal thoughts.

This blog explains how Spravato works, who qualifies, what the treatment involves, and how to find the right provider to begin this innovative approach to care.

What Is Spravato Esketamine Therapy?

Spravato is a prescription nasal spray that contains esketamine, a fast-acting compound derived from ketamine. Approved by the FDA, Spravato is used in conjunction with a daily oral antidepressant and is administered under the supervision of a licensed clinician.

How It Differs from Traditional Antidepressants

  • Target: While most antidepressants work on serotonin or norepinephrine, Spravato acts on the glutamate system, which plays a key role in mood regulation and neuroplasticity.
  • Administration: Spravato is self-administered in a certified clinic, followed by a period of observation.
  • Use Case: Designed for individuals with treatment-resistant depression (TRD) or major depressive disorder (MDD) with suicidal ideation.

Spravato esketamine therapy is not a first-line treatment, but for those who have tried multiple oral medications without success, it may offer a critical turning point in care.

Who Is Eligible for Spravato Therapy?

Spravato is intended for adults who have not responded to at least two different antidepressants and are under the care of a licensed psychiatric provider.

Candidates May Include:

  • Adults with treatment-resistant depression, despite multiple medication trials.
  • Individuals with MDD and active suicidal thoughts or behaviors.
  • Patients currently working with a psychiatrist and open to supervised in-clinic care.

Not Recommended For:

  • People with uncontrolled high blood pressure or cardiovascular conditions.
  • Those with a history of substance misuse or active addiction.
  • Individuals experiencing active psychosis or dissociative disorders.

A psychiatric evaluation is required to assess eligibility, safety, and treatment fit. At Community Minds, our team carefully screens each client to ensure Spravato is both safe and appropriate for their needs.

How Spravato Works in the Brain

One of the reasons Spravato esketamine therapy stands out is how quickly it acts and how differently it targets the brain compared to traditional antidepressants.

Mechanism of Action

  • Spravato targets the NMDA receptor, part of the brain’s glutamate system.
  • It increases glutamate levels, promoting neuroplasticity, the brain’s ability to rewire and heal itself.
  • This helps “reset” dysfunctional mood circuits often found in individuals with chronic depression.

Fast Results

Some patients begin to experience symptom relief within 24 to 48 hours of their first few doses. While results vary, this rapid onset of action can be life-changing for individuals who have felt stuck for years.

Spravato Esketamine Therapy

What to Expect During Spravato Treatment

Spravato ketamine treatment is always administered in a REMS-certified clinic to ensure safety and proper monitoring. Here’s what a typical treatment session looks like:

In-Clinic Procedure

  • You’ll arrive at the clinic and self-administer the nasal spray in a quiet, private setting.
  • A licensed provider will monitor your vitals and mental state throughout the process.
  • Most clients rest or relax in a calm space during their visit.

Observation Period

  • After each dose, you’ll remain in the clinic for at least two hours to ensure safety.
  • Providers are available to manage any side effects, such as dizziness, nausea, or dissociation.
  • Most side effects resolve by the end of the observation period.

Treatment Schedule

  • Weeks 1-4: Two sessions per week.
  • Weeks 5-8: One session per week.
  • Beyond week 9: Frequency tapers to every 1-2 weeks depending on your progress.

At Community Minds, we work closely with you throughout the entire process, adjusting your schedule and care plan based on how you're responding.

Finding a Spravato Provider Near You

Because Spravato requires specialized oversight, not all mental health clinics offer it. It's important to seek care from a REMS-certified provider with psychiatric expertise.

What to Look For

  • Clinics with REMS certification to administer Spravato.
  • A care team that includes psychiatrists or psychiatric nurse practitioners.
  • Experience working with treatment-resistant depression and suicidal ideation.

Questions to Ask a Provider

  • “Do you coordinate care with my existing mental health provider?”
  • “What kind of follow-up or aftercare support do you offer?”
  • “Does your clinic accept my insurance for Spravato?”
  • “Do you offer telepsychiatry for the initial evaluation?”

While some evaluations can be done remotely, Spravato treatment must be administered in person at a certified location. Community Minds offers a streamlined intake process to assess eligibility and get you started on a safe path to recovery.

Considering Spravato Esketamine Therapy for Depression?

For those struggling with severe, treatment-resistant depression, Spravato esketamine therapy offers a fast-acting, evidence-based alternative to traditional care. Backed by medical research and delivered under expert supervision, this therapy has helped many patients feel relief after years of frustration with standard medications.

If you’ve tried multiple antidepressants with little success, or if you’re dealing with urgent symptoms like suicidal thoughts, Spravato may offer a new path forward.

At Community Minds, our licensed professionals are trained to administer Spravato ketamine treatment in a safe, compassionate setting. Let us help you explore whether this therapy is right for you.

Find relief today!

Frequently Asked Questions
Spravato esketamine therapy is a fast-acting nasal spray treatment for adults with treatment-resistant depression or suicidal ideation. It’s administered in a certified clinic under medical supervision.
Spravato acts on the brain’s glutamate system instead of serotonin. It helps increase neuroplasticity and “reset” mood-related brain pathways, often producing faster results.
Some patients notice symptom improvements within 24-48 hours, though full results may take several sessions.
No. Spravato must be administered in person at a REMS-certified clinic. Patients are monitored on-site for at least two hours after each dose.
A psychiatric evaluation is required. Community Minds can help determine whether Spravato is safe and appropriate based on your medical history and symptoms.

Disclaimer: The information provided here is for informational purposes only and should not be considered professional advice. Always seek guidance from a qualified professional before making decisions based on this content.

Two friends hugging and smiling outdoors
Smiling young man and woman outdoors

Take the First Step Today

Find out which plans are covered. Unsure? Give us a call.

Free resources, created just for you!

Access articles, blogs, meditations and more. Have suggestions for free resources? Contact us.

 
A woman with brown hair and headphones sitting in a chair and holding a tablet in one hand, and glass of water in the other
How to Recognize When You Need Mental Health Support
A man doing power cleans at the gym